Annual Scientific Meeting San Francisco Neurological Society Annual Meeting - March 12-14, 2004, The Lodge at Sonoma, A Renaissance Resort & Spa - Program Co-Chairs: Jerome Barakos, MD & Michael McDermott, MD FINAL PROGRAM
Friday March 12, 2004
6:00 – 9:00 PM Registration in the Blue Oak Room
7:30 – 9:30 PM President’s Reception – in the Stone Building
Saturday March 13, 2004
7:00 AM Breakfast Buffet, Registration & Exhibits in the Blue Oak Room & Patio
8:00–9:00 AM Spouse Breakfast in the Blue Oak Room & Patio
8 – 8:45 AM Current and Emerging Therapies for Multiple Sclerosis Treatment, Bruce Cree, MD, PhD, Department of Neurology, UCSF, Multiple Sclerosis Center, San Francisco, CA, USA
Dr. Cree’s presentation is supported by an unrestricted educational grant from Pfizer
KEYNOTE PRESENTATION:
8:45 – 9:45 AM Regulation, Litigation and Frustration: Selected Aspects of Neurosurgery’s Response to Outside Challenges, Ralph G. Dacey, Jr., MD, Henry G & Edith R. Schwartz Professor and Chairman of Neurological Surgery, Washington University School of Medicine, St. Louis, MO
Dr. Dacey’s presentation is partially supported by UCSF, Department of Neurosurgery
9:45 – 10: 15 AM Coffee Break - Visit the Exhibits in the Blue Oak Room
SESSION I: PAIN AND NERVES
10:15 – 11:00 AM Effective use of IVIg in Neuropathy, Jonathan S. Katz, MD, Department of Neurology, Stanford University Medical Center, Palo Alto, CA
Dr. Katz’s presentation is supported by an unrestricted educational grant from Baxter
11:00 – 11:30 AM Neurochemical Basis of Pain, Michael Rowbotham, MD, Department of Neurology, UCSF, San Francisco, CA
Dr. Rowbotham’s presentation is supported by an unrestricted educational grant from Endo Pharmaceuticals
11:30 - 12:00 PM MR Neurography: Imaging of Peripheral Nerves, Cynthia Chin, MD & Phil Weinstein, MD, Department of Radiology, UCSF, San Francisco, CA
12:00 – 12:15 PM FXTAS (Fragile X-associated Tremor Ataxia Syndrome): A Newly Recognized Heritable Cause of Parkinsonism, Claudia Greco, MD, University of California, Davis, Sacrament, CA
12:15 - 12:30 PM DISCUSSION
12:30 - 6:00 PM Free for Lunch, Annual Golf Tournament & Activities
6:00 – 7:00 PM Reception in the Lobby Piano Lounge
7:00 – 9:00 PM Society Dinner in the Stone Building, Annual Dinner Meeting Presentation: From Neurosurgeon to Vineyardist! Dr. Thomas Kenefick, Calistoga, CA.
Dr. Thomas Kenefick, a San Francisco neurosurgeon and member of the SF Neurological Society will talk about his career change from well known neurosurgeon to successful wine grower. His grapes are sought by many local vineyards and he will soon be releasing his own wines. This presentation will be fun and informative for anyone who has an interest in wine and/or the inclination to make a drastic career change.
Sunday March 14, 2004
7:00 AM Continental Breakfast & Registration in the Blue Oak Room
8:00 – 9:00 AM Spouse Breakfast in the Blue Oak Room
8:00 – 8:30 AM Henry Newman Award Lecture: Stereotactic Radiosurgery for Intramedullary Spinal Tumors, Stephen Ryu, MD, Stanford University Medical Center, Neurological Surgery Resident
8:30 – 9:00 AM Edwin Boldrey Award Lecture: Unique Astrocyte Ribbon in Adult Human Brain Contains Neural Stem Cells but Lacks Neuronal Chain Migration, Nader Sanai, MD, UCSF Neurological Surgery Resident
SESSION II: STROKE, AGING & ADVANCES IN IMAGING
9:00 – 9:30 AM Neurochemical Basis of Stroke Protection, Raymond Swanson, MD, Department of Neurology, UCSF, San Francisco, CA
9:30 –10:00 AM Update on Management of Stroke, David C Tong, MD, Stanford Stroke Center, Stanford, CA
10:00 – 10:30 AM Coffee Break - Visit the exhibits in the Blue Oak Room
10:30– 11:00 AM Evolving Modalities in Brain Imaging: Latest Developments in Perfusion, Diffusion, T2 Relaxometry, and Proton MR Spectroscopy, Soonmee Cha, MD, UCSF School of Medicine, San Francisco, CA.
11:00 – 11:30 AM Memory and Aging, Bruce L. Miller, MD, Department of Neurology, UCSF, Memory and Aging Center, San Francisco, CA
11:30 – 12:00 PM Updates in Neuroimaging of Multiple Sclerosis, Daniel Pelletier, MD - UCSF, MS Center, San Francisco, CA
Dr. Pelletier’s presentation is supported by an unrestricted educational grant from Biogen
12:00 – 12:15 PM Surgery for Falcotentorial Meningiomas, Michael McDermott, MD, UCSF, San Francisco, CA
12:15 – 12:30 PM DISCUSSION
12:30 – 12:45 PM General Member’s Business Meeting
12:30 PM Adjourn
Educational Objectives & Continuing Medical Education
EDUCATIONAL OBJECTIVES: Individuals attending this meeting will be able to:
1. Review the current disease modifying therapies for MS and be familiar with risks/benefits of FDA approved disease modifying therapies
2. Discuss the rationale and study design for ongoing and upcoming treatment trials in MS and that several promising clinical trials are currently, or soon will be, enrolling study subjects
3. Compare and discuss off-label usage of treatments available at UCSF for treatment of refractory MS disease to FDA approved therapies with illustrative case presentations
4. Discuss the scope of medical malpractice litigation in the US as it relates to neurosurgery.
5. Describe organized neurosurgery's response to the malpractice problem and liability crisis.
6. Describe the properties of IVIg and its suspected mechanisms of action in the treatment of neuromuscular disease.
7. Describe the indications for the use of IVIg in neuromuscular disorders.
8. Compare and contrast the risk/benefit profile of IVIg versus other treatment options for autoimmune neuromuscular disease.
9. Apply optimal strategies for dosing and administration if IVIg, for both short-and long-term therapy, based on current knowledge.
10. Recognize the neurochemical processes triggered by ischemia that lead to neuronal death and interventions that can interrupt these processes
11. Describe basic technique and clinical application of advanced neuroimaging: perfusion, diffusion, and spectroscopic MR imaging
12. Discuss quantitative MR Imaging and its application to neurodegenerative aspects of MS, HMRS, DTI and brain atrophy
WHO SHOULD ATTEND:
Neurologists, neurosurgeons, neuroradiologists, residents and other physicians interested in research and clinical advances in the neurosciences.
Accreditation Statement
This is an activity offered by San Francisco Neurological Society, a CMA-accredited provider. Physicians attending this course may report up to 8 hours of Category 1 credits toward the California Medical Association’s Certification in Continuing Medical Education and the American Medical Association’s Physician’s Recognition Award. Each physician should claim only those hours of credit actually spent in the educational activity.
Faculty Addendum Conflict of Interest Information
The San Francisco Neurological Society has a conflict of interest policy that requires course faculty to disclose whether or not they have financial interests or affiliations with organizations with a direct and substantial interest in the subject matter of their presentations. The following information was received from course faculty. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations. They simply are noted here to fully inform course participants.
Speakers: The following speakers have indicated that they have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of their presentations.
Name Affiliation
Bruce Cree MD, PhD Grant support from NIH, National Multiple Sclerosis Society; Honoraria from Biogen-Idec, Serono-Pfizer, Berlex, Teva Neurosciences
Jonathan Katz, MD Honoraria from Baxter
Bruce Miller, MD Honoraria from Pfizer and Janssen Pharmaceutica
Daniel Pelletier, MD Honoraria from Biogen-Idec
David C. Tong, MD Consultant for & Honoraria from Bristol-Myers Squibb Co., Sanofi, Boehringer Ingelheim and Wyeth
Michael Rowbotham, MD Honoraria from Endo Pharmaceuticals
The following speakers have indicated that they have no actual or potential conflict of interest in relation to this program:
Soonmee Cha, MD, Ralph Dacey, MD, , Cynthia Chin, MD, Stephen Ryu, MD, Nader Sanai, MD and Raymond Swanson, MD
Discussion of Off-Label or Investigational Uses
The following speakers have indicated that they will be discussing Off-Label or Investigations Uses of commercial products in their presentation: Bruce Cree, MD, PhD, And Jonathan Katz, MD | | Home
MembershipNewsletters Sponsors Board of
Directors
Related Links
|
